Review
doi: 10.1016/0305-7372(86)90001-0.
Differentiating agents in the treatment of human malignancies
- PMID: 3536087
- DOI: 10.1016/0305-7372(86)90001-0
Item in Clipboard
Review
Differentiating agents in the treatment of human malignancies
Cancer Treat Rev.
1986 Sep.
No abstract available
Similar articles
-
Bench-to-bedside research and the human tumor stem-cell assay--bridging the credibility gap.J Clin Oncol. 1986 Dec;4(12):1730-1. doi: 10.1200/JCO.1986.4.12.1730. J Clin Oncol. 1986. PMID: 3783200 No abstract available.
-
Design of adjuvant chemotherapy based on target cell determinants of drug action: possibilities and limitations.Recent Results Cancer Res. 1979;67:126-31. doi: 10.1007/978-3-642-81320-7_19. Recent Results Cancer Res. 1979. PMID: 377431 Clinical Trial. No abstract available.
-
The conduct of therapeutic trials in cancer medicine.Semin Oncol. 1977 Jun;4(2):255-8. Semin Oncol. 1977. PMID: 327556 Clinical Trial. No abstract available.
-
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.Semin Oncol. 1985 Jun;12(2 Suppl 3):177-83. Semin Oncol. 1985. PMID: 3892699 Review. No abstract available.
-
Drug latentiation in cancer chemotherapy.Biomedicine. 1978 Oct;28(5):255-62. Biomedicine. 1978. PMID: 369628 Review.
Cited by
-
The effect of sodium butyrate on the growth characteristics of human cervix tumour cells.Br J Cancer. 1992 Jun;65(6):803-8. doi: 10.1038/bjc.1992.172. Br J Cancer. 1992. PMID: 1377482 Free PMC article.
-
How frequent is spontaneous remission of neuroblastomas? Implications for screening.Br J Cancer. 1990 Mar;61(3):441-6. doi: 10.1038/bjc.1990.97. Br J Cancer. 1990. PMID: 2328213 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
